WhiteSwell Announces Successful Treatment of Acute Decompens

GALWAY, Ireland, October 07, 2023--WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive initial results from its ongoing DELTA-HF trial evaluating the WhiteSwell eLym™ System. The data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in Cleveland, Ohio.

Related Keywords

Ohio , United States , Ireland , Tbilisi , Georgia General , Georgia , Cleveland , America , William Abraham , Martens Mullens , Coll Cardiol , Zviad Kereselidze , Heart Failure Society Of America , International Journal Of Cardiology , Tbilisi Heart Center , Ohio State University Wexner Medical Center , Heart Failure Society , Annual Scientific Meeting , Elym System , Cell Biology , Ohio State University Wexner Medical , Tbilisi Heart , Excess Lymphatic Fluid , Thoracic Duct , Acute Decompensated Heart Failure , Lymphatic System , Koreanj Intern Med , Integrative Assessment , Heart Failure Throughout , Patient Journey , Nature Reviews Disease Primers , International Journal , Delta Hf , Excess Fluid , Iuretic Therapy , Heart Failure , Hospital Discharge , Loop Diuretics , Adhf , Vascular System , Congestion , Interstitial Fluid , Ymphatic Vessel ,